The rising prevalence of urine incontinence and the rising incidence of urinary tract infections are mostly to blame for the expansion of the Global Overactive Bladder Treatment Market. However, the market expansion is hampered by the recalls of medicinal pharmaceuticals. The overactive bladder treatment market was dominated by North America in 2022. The overactive bladder treatment market in North America is expanding due to the rising incidence of neurological diseases and the rising prevalence of overactive bladder in the elderly population. The growth of the North American market is also fueled by favourable reimbursement scenarios for the treatment of overactive bladder and an increase in research activities.
Read more- https://cmi-latestreportorientedblogs.blogspot.com/2022/11/overactive-bladder-treatment-market.html
